<html xmlns:mso="urn:schemas-microsoft-com:office:office" xmlns:msdt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title></title>
<style type="text/css">
<!--
.Insert {  color: #339933; text-decoration: underline}
.Remove {  color: #FF0000; text-decoration: line-through}
-->
</style>

<!--[if gte mso 9]><xml>
<mso:CustomDocumentProperties>
<mso:BillNumber msdt:dt="string">432</mso:BillNumber>
<mso:BillSubject msdt:dt="string">Controlled Substances</mso:BillSubject>
<mso:BillFiledDate msdt:dt="string">2025-11-07T10:18:58Z</mso:BillFiledDate>
<mso:BillShortTitle msdt:dt="string">Adding 7-Hydroxymitragynine as a Schedule I controlled substance; excepting from the list of Schedule I controlled substances certain xylazine animal drug products approved by the United States Food and Drug Administration and used for certain purposes; providing criminal penalties and requiring a mandatory minimum term of imprisonment if a person sells, manufactures, or delivers or possesses with intent to sell, manufacture, or deliver xylazine; creating the offense of trafficking in xylazine; providing criminal penalties and requiring a mandatory minimum term of imprisonment and fines based on the quantity of the controlled substance involved in the offense, etc.</mso:BillShortTitle>
<mso:BillVersionName msdt:dt="string">Original Filed Version</mso:BillVersionName>
<mso:BillLegislativeSessionName msdt:dt="string">2026</mso:BillLegislativeSessionName>
<mso:BillChamber msdt:dt="string">S</mso:BillChamber>
<mso:BillTypeAbbreviation msdt:dt="string">GB</mso:BillTypeAbbreviation>
<mso:BillTypeName msdt:dt="string">General Bill</mso:BillTypeName>
<mso:BillVersion msdt:dt="string">__</mso:BillVersion>
</mso:CustomDocumentProperties>
</xml><![endif]-->
</head>
<body>
<pre style="line-height: 1.5em; font-size: 12px">
       <b>Florida Senate</b> - <b>2026</b>                                     <b>SB 432</b><b></b>
       <b></b>
       
        
       <b>By </b>Senator Yarborough
       
       
       
       
       
       4-00311B-26                                            2026432__
    1                        A bill to be entitled                      
    2         An act relating to controlled substances; amending s.
    3         893.03, F.S.; adding 7-Hydroxymitragynine as a
    4         Schedule I controlled substance; excepting from the
    5         list of Schedule I controlled substances certain
    6         xylazine animal drug products approved by the United
    7         States Food and Drug Administration and used for
    8         certain purposes; amending s. 893.13, F.S.; providing
    9         criminal penalties and requiring a mandatory minimum
   10         term of imprisonment if a person sells, manufactures,
   11         or delivers or possesses with intent to sell,
   12         manufacture, or deliver xylazine; amending s. 893.135,
   13         F.S.; creating the offense of trafficking in xylazine;
   14         providing criminal penalties and requiring a mandatory
   15         minimum term of imprisonment and fines based on the
   16         quantity of the controlled substance involved in the
   17         offense; providing effective dates.
   18          
   19  Be It Enacted by the Legislature of the State of Florida:
   20  
   21         Section 1.âEffective July 1, 2026, paragraphs (a) and (c)
   22  of subsection (1) of section 893.03, Florida Statutes, are
   23  amended to read:
   24         893.03âStandards and schedules.âThe substances enumerated
   25  in this section are controlled by this chapter. The controlled
   26  substances listed or to be listed in Schedules I, II, III, IV,
   27  and V are included by whatever official, common, usual,
   28  chemical, trade name, or class designated. The provisions of
   29  this section shall not be construed to include within any of the
   30  schedules contained in this section any excluded drugs listed
   31  within the purview of 21 C.F.R. s. 1308.22, styled âExcluded
   32  Substancesâ; 21 C.F.R. s. 1308.24, styled âExempt Chemical
   33  Preparationsâ; 21 C.F.R. s. 1308.32, styled âExempted
   34  Prescription Productsâ; or 21 C.F.R. s. 1308.34, styled âExempt
   35  Anabolic Steroid Products.â
   36         (1)âSCHEDULE I.âA substance in Schedule I has a high
   37  potential for abuse and has no currently accepted medical use in
   38  treatment in the United States and in its use under medical
   39  supervision does not meet accepted safety standards. The
   40  following substances are controlled in Schedule I:
   41         (a)âUnless specifically excepted or unless listed in
   42  another schedule, any of the following substances, including
   43  their isomers, esters, ethers, salts, and salts of isomers,
   44  esters, and ethers, whenever the existence of such isomers,
   45  esters, ethers, and salts is possible within the specific
   46  chemical designation:
   47         1.âAcetyl-alpha-methylfentanyl.
   48         2.âAcetylmethadol.
   49         3.âAllylprodine.
   50         4.âAlphacetylmethadol (except levo-alphacetylmethadol, also
   51  known as levo-alpha-acetylmethadol, levomethadyl acetate, or
   52  LAAM).
   53         5.âAlphamethadol.
   54         6.âAlpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl)
   55  ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4
   56  (N-propanilido) piperidine).
   57         7.âAlpha-methylthiofentanyl.
   58         8.âAlphameprodine.
   59         9.âBenzethidine.
   60         10.âBenzylfentanyl.
   61         11.âBetacetylmethadol.
   62         12.âBeta-hydroxyfentanyl.
   63         13.âBeta-hydroxy-3-methylfentanyl.
   64         14.âBetameprodine.
   65         15.âBetamethadol.
   66         16.âBetaprodine.
   67         17.âClonitazene.
   68         18.âDextromoramide.
   69         19.âDiampromide.
   70         20.âDiethylthiambutene.
   71         21.âDifenoxin.
   72         22.âDimenoxadol.
   73         23.âDimepheptanol.
   74         24.âDimethylthiambutene.
   75         25.âDioxaphetyl butyrate.
   76         26.âDipipanone.
   77         27.âEthylmethylthiambutene.
   78         28.âEtonitazene.
   79         29.âEtoxeridine.
   80         30.âFlunitrazepam.
   81         31.âFurethidine.
   82         32.âHydroxypethidine.
   83         33.âKetobemidone.
   84         34.âLevomoramide.
   85         35.âLevophenacylmorphan.
   86         36.âDesmethylprodine (1-Methyl-4-Phenyl-4
   87  Propionoxypiperidine).
   88         37.â3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4
   89  piperidyl]-N-phenylpropanamide).
   90         38.â3-Methylthiofentanyl.
   91         39.âMorpheridine.
   92         40.âNoracymethadol.
   93         41.âNorlevorphanol.
   94         42.âNormethadone.
   95         43.âNorpipanone.
   96         44.âPara-Fluorofentanyl.
   97         45.âPhenadoxone.
   98         46.âPhenampromide.
   99         47.âPhenomorphan.
  100         48.âPhenoperidine.
  101         49.âPEPAP (1-(2-Phenylethyl)-4-Phenyl-4
  102  Acetyloxypiperidine).
  103         50.âPiritramide.
  104         51.âProheptazine.
  105         52.âProperidine.
  106         53.âPropiram.
  107         54.âRacemoramide.
  108         55.âThenylfentanyl.
  109         56.âThiofentanyl.
  110         57.âTianeptine.
  111         58.âTilidine.
  112         59.âTrimeperidine.
  113         60.âAcetylfentanyl.
  114         61.âButyrylfentanyl.
  115         62.âBeta-Hydroxythiofentanyl.
  116         63.âFentanyl derivatives. Unless specifically excepted,
  117  listed in another schedule, or contained within a pharmaceutical
  118  product approved by the United States Food and Drug
  119  Administration, any material, compound, mixture, or preparation,
  120  including its salts, isomers, esters, or ethers, and salts of
  121  isomers, esters, or ethers, whenever the existence of such salts
  122  is possible within any of the following specific chemical
  123  designations containing a 4-anilidopiperidine structure:
  124         a.âWith or without substitution at the carbonyl of the
  125  aniline moiety with alkyl, alkenyl, carboalkoxy, cycloalkyl,
  126  methoxyalkyl, cyanoalkyl, or aryl groups, or furanyl,
  127  dihydrofuranyl, benzyl moiety, or rings containing heteroatoms
  128  sulfur, oxygen, or nitrogen;
  129         b.âWith or without substitution at the piperidine amino
  130  moiety with a phenethyl, benzyl, alkylaryl (including
  131  heteroaromatics), alkyltetrazolyl ring, or an alkyl or
  132  carbomethoxy group, whether or not further substituted in the
  133  ring or group;
  134         c.âWith or without substitution or addition to the
  135  piperdine ring to any extent with one or more methyl,
  136  carbomethoxy, methoxy, methoxymethyl, aryl, allyl, or ester
  137  groups;
  138         d.âWith or without substitution of one or more hydrogen
  139  atoms for halogens, or methyl, alkyl, or methoxy groups, in the
  140  aromatic ring of the anilide moiety;
  141         e.âWith or without substitution at the alpha or beta
  142  position of the piperidine ring with alkyl, hydroxyl, or methoxy
  143  groups;
  144         f.âWith or without substitution of the benzene ring of the
  145  anilide moiety for an aromatic heterocycle; and
  146         g.âWith or without substitution of the piperidine ring for
  147  a pyrrolidine ring, perhydroazepine ring, or azepine ring;
  148  
  149  excluding, Alfentanil, Carfentanil, Fentanyl, and Sufentanil;
  150  including, but not limited to:
  151         (I)âAcetyl-alpha-methylfentanyl.
  152         (II)âAlpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl)
  153  ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4
  154  (N-propanilido) piperidine).
  155         (III)âAlpha-methylthiofentanyl.
  156         (IV)âBenzylfentanyl.
  157         (V)âBeta-hydroxyfentanyl.
  158         (VI)âBeta-hydroxy-3-methylfentanyl.
  159         (VII)â3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4
  160  piperidyl]-N-phenylpropanamide).
  161         (VIII)â3-Methylthiofentanyl.
  162         (IX)âPara-Fluorofentanyl.
  163         (X)âThenylfentanyl or Thienyl fentanyl.
  164         (XI)âThiofentanyl.
  165         (XII)âAcetylfentanyl.
  166         (XIII)âButyrylfentanyl.
  167         (XIV)âBeta-Hydroxythiofentanyl.
  168         (XV)âLofentanil.
  169         (XVI)âOcfentanil.
  170         (XVII)âOhmfentanyl.
  171         (XVIII)âBenzodioxolefentanyl.
  172         (XIX)âFuranyl fentanyl.
  173         (XX)âPentanoyl fentanyl.
  174         (XXI)âCyclopentyl fentanyl.
  175         (XXII)âIsobutyryl fentanyl.
  176         (XXIII)âRemifentanil.
  177         64.âNitazene derivatives. Unless specifically excepted,
  178  listed in another schedule, or contained within a pharmaceutical
  179  product approved by the United States Food and Drug
  180  Administration, any material, compound, mixture, or preparation,
  181  including its salts, isomers, esters, or ethers, and salts of
  182  isomers, esters, or ethers, whenever the existence of such salts
  183  is possible within any of the following specific chemical
  184  designations containing a benzimidazole ring with an ethylamine
  185  substitution at the 1-position and a benzyl ring substitution at
  186  the 2-position structure:
  187         a.âWith or without substitution on the benzimidazole ring
  188  with alkyl, alkoxy, carboalkoxy, amino, nitro, or aryl groups,
  189  or halogens;
  190         b.âWith or without substitution at the ethylamine amino
  191  moiety with alkyl, dialkyl, acetyl, or benzyl groups, whether or
  192  not further substituted in the ring system;
  193         c.âWith or without inclusion of the ethylamine amino moiety
  194  in a cyclic structure;
  195         d.âWith or without substitution of the benzyl ring; or
  196         e.âWith or without replacement of the benzyl ring with an
  197  aromatic ring, including, but not limited to:
  198         (I)âButonitazene.
  199         (II)âClonitazene.
  200         (III)âEtodesnitazene.
  201         (IV)âEtonitazene.
  202         (V)âFlunitazene.
  203         (VI)âIsotodesnitazene.
  204         (VII)âIsotonitazene.
  205         (VIII)âMetodesnitazene.
  206         (IX)âMetonitazene.
  207         (X)âNitazene.
  208         (XI)âN-Desethyl Etonitazene.
  209         (XII)âN-Desethyl Isotonitazene.
  210         (XIII)âN-Piperidino Etonitazene.
  211         (XIV)âN-Pyrrolidino Etonitazene.
  212         (XV)âProtonitazene.
  213         <u class="Insert">65.</u><u class="Insert">â</u><u class="Insert">7-Hydroxymitragynine (methyl (E)-2</u><u class="Insert">-</u><u class="Insert">[(2S,3S,7aS,12bS)-3</u>
  214  <u class="Insert">ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H</u>
  215  <u class="Insert">indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate)</u>
  216  <u class="Insert">concentrated at a level above </u><u class="Insert">400</u><u class="Insert"> parts per million on a dry</u>
  217  <u class="Insert">weight basis</u><u class="Insert">.</u>
  218         (c)âUnless specifically excepted or unless listed in
  219  another schedule, any material, compound, mixture, or
  220  preparation that contains any quantity of the following
  221  hallucinogenic substances or that contains any of their salts,
  222  isomers, including optical, positional, or geometric isomers,
  223  homologues, nitrogen-heterocyclic analogs, esters, ethers, and
  224  salts of isomers, homologues, nitrogen-heterocyclic analogs,
  225  esters, or ethers, if the existence of such salts, isomers, and
  226  salts of isomers is possible within the specific chemical
  227  designation or class description:
  228         1.âAlpha-Ethyltryptamine.
  229         2.â4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2
  230  oxazoline).
  231         3.âAminorex (2-Amino-5-phenyl-2-oxazoline).
  232         4.âDOB (4-Bromo-2,5-dimethoxyamphetamine).
  233         5.â2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
  234         6.âBufotenine.
  235         7.âCannabis.
  236         8.âCathinone.
  237         9.âDET (Diethyltryptamine).
  238         10.â2,5-Dimethoxyamphetamine.
  239         11.âDOET (4-Ethyl-2,5-Dimethoxyamphetamine).
  240         12.âDMT (Dimethyltryptamine).
  241         13.âPCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine
  242  analog of phencyclidine).
  243         14.âJB-318 (N-Ethyl-3-piperidyl benzilate).
  244         15.âN-Ethylamphetamine.
  245         16.âFenethylline.
  246         17.â3,4-Methylenedioxy-N-hydroxyamphetamine.
  247         18.âIbogaine.
  248         19.âLSD (Lysergic acid diethylamide).
  249         20.âMescaline.
  250         21.âMethcathinone.
  251         22.â5-Methoxy-3,4-methylenedioxyamphetamine.
  252         23.âPMA (4-Methoxyamphetamine).
  253         24.âPMMA (4-Methoxymethamphetamine).
  254         25.âDOM (4-Methyl-2,5-dimethoxyamphetamine).
  255         26.âMDEA (3,4-Methylenedioxy-N-ethylamphetamine).
  256         27.âMDA (3,4-Methylenedioxyamphetamine).
  257         28.âJB-336 (N-Methyl-3-piperidyl benzilate).
  258         29.âN,N-Dimethylamphetamine.
  259         30.âParahexyl.
  260         31.âPeyote.
  261         32.âPCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
  262  analog of phencyclidine).
  263         33.âPsilocybin.
  264         34.âPsilocyn.
  265         35.â<i>Salvia divinorum</i>, except for any drug product approved
  266  by the United States Food and Drug Administration which contains
  267  <i>Salvia divinorum</i> or its isomers, esters, ethers, salts, and
  268  salts of isomers, esters, and ethers, if the existence of such
  269  isomers, esters, ethers, and salts is possible within the
  270  specific chemical designation.
  271         36.âSalvinorin A, except for any drug product approved by
  272  the United States Food and Drug Administration which contains
  273  Salvinorin A or its isomers, esters, ethers, salts, and salts of
  274  isomers, esters, and ethers, if the existence of such isomers,
  275  esters, ethers, and salts is possible within the specific
  276  chemical designation.
  277         37.âXylazine<u class="Insert">, except for a xylazine animal drug product</u>
  278  <u class="Insert">approved by the United States Food and Drug Administration and</u>
  279  <u class="Insert">the use of which conforms to the approved application or is</u>
  280  <u class="Insert">authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,</u>
  281  <u class="Insert">importation, distribution, prescribing, or sale of xylazine for</u>
  282  <u class="Insert">human use is not subject to this exception</u>.
  283         38.âTCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
  284  (Thiophene analog of phencyclidine).
  285         39.â3,4,5-Trimethoxyamphetamine.
  286         40.âMethylone (3,4-Methylenedioxymethcathinone).
  287         41.âMDPV (3,4-Methylenedioxypyrovalerone).
  288         42.âMethylmethcathinone.
  289         43.âMethoxymethcathinone.
  290         44.âFluoromethcathinone.
  291         45.âMethylethcathinone.
  292         46.âCP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
  293  yl)phenol) and its dimethyloctyl (C8) homologue.
  294         47.âHU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2
  295  methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].
  296         48.âJWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
  297         49.âJWH-073 (1-Butyl-3-(1-naphthoyl)indole).
  298         50.âJWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
  299  naphthoyl)indole).
  300         51.âBZP (Benzylpiperazine).
  301         52.âFluorophenylpiperazine.
  302         53.âMethylphenylpiperazine.
  303         54.âChlorophenylpiperazine.
  304         55.âMethoxyphenylpiperazine.
  305         56.âDBZP (1,4-Dibenzylpiperazine).
  306         57.âTFMPP (Trifluoromethylphenylpiperazine).
  307         58.âMBDB (Methylbenzodioxolylbutanamine) or (3,4
  308  Methylenedioxy-N-methylbutanamine).
  309         59.â5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
  310         60.â5-Hydroxy-N-methyltryptamine.
  311         61.â5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
  312         62.â5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
  313         63.âMethyltryptamine.
  314         64.â5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
  315         65.â5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
  316         66.âTyramine (4-Hydroxyphenethylamine).
  317         67.â5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
  318         68.âDiPT (N,N-Diisopropyltryptamine).
  319         69.âDPT (N,N-Dipropyltryptamine).
  320         70.â4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
  321         71.â5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
  322         72.âDOI (4-Iodo-2,5-dimethoxyamphetamine).
  323         73.âDOC (4-Chloro-2,5-dimethoxyamphetamine).
  324         74.â2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
  325         75.â2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
  326         76.â2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
  327         77.â2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
  328         78.â2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
  329         79.â2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
  330         80.â2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
  331         81.âButylone (3,4-Methylenedioxy-alpha
  332  methylaminobutyrophenone).
  333         82.âEthcathinone.
  334         83.âEthylone (3,4-Methylenedioxy-N-ethylcathinone).
  335         84.âNaphyrone (Naphthylpyrovalerone).
  336         85.âDimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).
  337         86.â3,4-Methylenedioxy-N,N-diethylcathinone.
  338         87.â3,4-Methylenedioxy-propiophenone.
  339         88.â3,4-Methylenedioxy-alpha-bromopropiophenone.
  340         89.â3,4-Methylenedioxy-propiophenone-2-oxime.
  341         90.â3,4-Methylenedioxy-N-acetylcathinone.
  342         91.â3,4-Methylenedioxy-N-acetylmethcathinone.
  343         92.â3,4-Methylenedioxy-N-acetylethcathinone.
  344         93.âBromomethcathinone.
  345         94.âBuphedrone (alpha-Methylamino-butyrophenone).
  346         95.âEutylone (3,4-Methylenedioxy-alpha
  347  ethylaminobutyrophenone).
  348         96.âDimethylcathinone.
  349         97.âDimethylmethcathinone.
  350         98.âPentylone (3,4-Methylenedioxy-alpha
  351  methylaminovalerophenone).
  352         99.âMDPPP (3,4-Methylenedioxy-alpha
  353  pyrrolidinopropiophenone).
  354         100.âMDPBP (3,4-Methylenedioxy-alpha
  355  pyrrolidinobutyrophenone).
  356         101.âMOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
  357         102.âMPHP (Methyl-alpha-pyrrolidinohexanophenone).
  358         103.âBTCP (Benzothiophenylcyclohexylpiperidine) or BCP
  359  (Benocyclidine).
  360         104.âF-MABP (Fluoromethylaminobutyrophenone).
  361         105.âMeO-PBP (Methoxypyrrolidinobutyrophenone).
  362         106.âEt-PBP (Ethylpyrrolidinobutyrophenone).
  363         107.â3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
  364         108.âMe-EABP (Methylethylaminobutyrophenone).
  365         109.âEtizolam.
  366         110.âPPP (Pyrrolidinopropiophenone).
  367         111.âPBP (Pyrrolidinobutyrophenone).
  368         112.âPVP (Pyrrolidinovalerophenone) or
  369  (Pyrrolidinopentiophenone).
  370         113.âMPPP (Methyl-alpha-pyrrolidinopropiophenone).
  371         114.âJWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
  372         115.âJWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
  373         116.âJWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
  374         117.âJWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
  375         118.âJWH-072 (1-Propyl-3-(1-naphthoyl)indole).
  376         119.âJWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
  377         120.âJWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
  378         121.âJWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
  379  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  380         122.âJWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
  381         123.âJWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
  382         124.âJWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
  383         125.âJWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
  384         126.âJWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
  385         127.âJWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
  386         128.âJWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
  387         129.âJWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
  388         130.âHU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
  389  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  390  ol).
  391         131.âHU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan
  392  2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]
  393  methanol).
  394         132.âHU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1
  395  methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene
  396  1,4-dione).
  397         133.âCB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
  398         134.âCB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)
  399  undecanamide).
  400         135.âCB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)
  401  undecanamide).
  402         136.âCP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2
  403  methyloctan-2-yl)phenol).
  404         137.âAM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
  405         138.âAM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
  406         139.âRCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
  407         140.âRCS-8 (1-(2-Cyclohexylethyl)-3-(2
  408  methoxyphenylacetyl)indole).
  409         141.âWIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
  410  morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
  411  naphthalenylmethanone).
  412         142.âWIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4
  413  morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
  414  naphthalenylmethanone).
  415         143.âPentedrone (alpha-Methylaminovalerophenone).
  416         144.âFluoroamphetamine.
  417         145.âFluoromethamphetamine.
  418         146.âMethoxetamine.
  419         147.âMethiopropamine.
  420         148.âMethylbuphedrone (Methyl-alpha
  421  methylaminobutyrophenone).
  422         149.âAPB ((2-Aminopropyl)benzofuran).
  423         150.âAPDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
  424         151.âUR-144 (1-Pentyl-3-(2,2,3,3
  425  tetramethylcyclopropanoyl)indole).
  426         152.âXLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
  427  tetramethylcyclopropanoyl)indole).
  428         153.âChloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
  429  tetramethylcyclopropanoyl)indole).
  430         154.âAKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
  431         155.âAM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  432  iodobenzoyl)indole).
  433         156.âSTS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
  434  carboxamide).
  435         157.âURB-597 ((3â²-(Aminocarbonyl)[1,1â²-biphenyl]-3-yl)
  436  cyclohexylcarbamate).
  437         158.âURB-602 ([1,1â²-Biphenyl]-3-yl-carbamic acid,
  438  cyclohexyl ester).
  439         159.âURB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1
  440  benzoxazin-4-one).
  441         160.â2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
  442         161.â2C-H (2,5-Dimethoxyphenethylamine).
  443         162.â2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
  444         163.â2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
  445         164.â25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
  446  methoxybenzyl)]phenethylamine).
  447         165.âMDMA (3,4-Methylenedioxymethamphetamine).
  448         166.âPB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
  449         167.âFluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
  450  carboxylate).
  451         168.âBB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
  452  carboxylate).
  453         169.âFluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
  454  3-carboxamide).
  455         170.âAB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  456  pentylindazole-3-carboxamide).
  457         171.âAB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  458  (4-fluorobenzyl)indazole-3-carboxamide).
  459         172.âADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
  460  1-pentylindazole-3-carboxamide).
  461         173.âFluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  462  yl)-1-(fluoropentyl)indole-3-carboxamide).
  463         174.â25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
  464  methoxybenzyl)]phenethylamine).
  465         175.â25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
  466  methoxybenzyl)]phenethylamine).
  467         176.âAB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  468  (cyclohexylmethyl)indazole-3-carboxamide).
  469         177.âFUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
  470  carboxylate).
  471         178.âFluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
  472  3-carboxamide).
  473         179.âFluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  474  (fluoropentyl)indazole-3-carboxamide).
  475         180.âTHJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
  476         181.âAM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl
  477  1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
  478         182.âAM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9
  479  (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
  480  hexahydrobenzo[c]chromen-1-ol).
  481         183.âAM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9
  482  (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
  483  hexahydrobenzo[c]chromen-1-ol).
  484         184.âAM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)
  485  6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
  486  diol).
  487         185.âHU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6
  488  dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a
  489  tetrahydro-6aH-benzo[c]chromen-1-ol).
  490         186.âHU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl
  491  6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
  492         187.âMAPB ((2-Methylaminopropyl)benzofuran).
  493         188.â5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
  494         189.â6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
  495         190.âSynthetic Cannabinoids.âUnless specifically excepted
  496  or unless listed in another schedule or contained within a
  497  pharmaceutical product approved by the United States Food and
  498  Drug Administration, any material, compound, mixture, or
  499  preparation that contains any quantity of a synthetic
  500  cannabinoid found to be in any of the following chemical class
  501  descriptions, or homologues, nitrogen-heterocyclic analogs,
  502  isomers (including optical, positional, or geometric), esters,
  503  ethers, salts, and salts of homologues, nitrogen-heterocyclic
  504  analogs, isomers, esters, or ethers, whenever the existence of
  505  such homologues, nitrogen-heterocyclic analogs, isomers, esters,
  506  ethers, salts, and salts of isomers, esters, or ethers is
  507  possible within the specific chemical class or designation.
  508  Since nomenclature of these synthetically produced cannabinoids
  509  is not internationally standardized and may continually evolve,
  510  these structures or the compounds of these structures shall be
  511  included under this subparagraph, regardless of their specific
  512  numerical designation of atomic positions covered, if it can be
  513  determined through a recognized method of scientific testing or
  514  analysis that the substance contains properties that fit within
  515  one or more of the following categories:
  516         a.âTetrahydrocannabinols.âAny tetrahydrocannabinols
  517  naturally contained in a plant of the genus <i>Cannabis</i>, the
  518  synthetic equivalents of the substances contained in the plant
  519  or in the resinous extracts of the genus <i>Cannabis</i>, or synthetic
  520  substances, derivatives, and their isomers with similar chemical
  521  structure and pharmacological activity, including, but not
  522  limited to, Delta 9 tetrahydrocannabinols and their optical
  523  isomers, Delta 8 tetrahydrocannabinols and their optical
  524  isomers, Delta 6a,10a tetrahydrocannabinols and their optical
  525  isomers, or any compound containing a tetrahydrobenzo[c]chromene
  526  structure with substitution at either or both the 3-position or
  527  9-position, with or without substitution at the 1-position with
  528  hydroxyl or alkoxy groups, including, but not limited to:
  529         (I)âTetrahydrocannabinol.
  530         (II)âHU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
  531  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  532  ol).
  533         (III)âHU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
  534  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  535  ol).
  536         (IV)âJWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
  537  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  538         (V)âJWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
  539  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  540         (VI)âJWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan
  541  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  542         (VII)âJWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3
  543  dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  544         (VIII)âAM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)
  545  6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
  546         (IX)âAM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl
  547  6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
  548         (X)âParahexyl.
  549         b.âNaphthoylindoles, Naphthoylindazoles,
  550  Naphthoylcarbazoles, Naphthylmethylindoles,
  551  Naphthylmethylindazoles, and Naphthylmethylcarbazoles.âAny
  552  compound containing a naphthoylindole, naphthoylindazole,
  553  naphthoylcarbazole, naphthylmethylindole,
  554  naphthylmethylindazole, or naphthylmethylcarbazole structure,
  555  with or without substitution on the indole, indazole, or
  556  carbazole ring to any extent, whether or not substituted on the
  557  naphthyl ring to any extent, including, but not limited to:
  558         (I)âJWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
  559         (II)âJWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1
  560  naphthoyl)indole).
  561         (III)âJWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
  562         (IV)âJWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
  563         (V)âJWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
  564         (VI)âJWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
  565         (VII)âJWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
  566         (VIII)âJWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
  567         (IX)âJWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
  568         (X)âJWH-072 (1-Propyl-3-(1-naphthoyl)indole).
  569         (XI)âJWH-073 (1-Butyl-3-(1-naphthoyl)indole).
  570         (XII)âJWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
  571         (XIII)âJWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
  572         (XIV)âJWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1
  573  naphthoyl)indole).
  574         (XV)âJWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
  575         (XVI)âJWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
  576         (XVII)âJWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1
  577  naphthoyl)indole).
  578         (XVIII)âJWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).
  579         (XIX)âJWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
  580         (XX)âJWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
  581         (XXI)âJWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
  582         (XXII)âJWH-184 (1-Pentyl-3-[(4-methyl)-1
  583  naphthylmethyl]indole).
  584         (XXIII)âJWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1
  585  naphthoyl)indole).
  586         (XXIV)âJWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1
  587  naphthoyl)indole).
  588         (XXV)âJWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
  589  naphthoyl)indole).
  590         (XXVI)âJWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
  591         (XXVII)âJWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
  592         (XXVIII)âJWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
  593         (XXIX)âJWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
  594         (XXX)âJWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
  595         (XXXI)âAM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1
  596  naphthoyl)indole).
  597         (XXXII)âAM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1
  598  naphthoyl)indole).
  599         (XXXIII)âAM-2201 (1-(5-Fluoropentyl)-3-(1
  600  naphthoyl)indole).
  601         (XXXIV)âChloro JWH-018 (1-(Chloropentyl)-3-(1
  602  naphthoyl)indole).
  603         (XXXV)âBromo JWH-018 (1-(Bromopentyl)-3-(1
  604  naphthoyl)indole).
  605         (XXXVI)âAM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
  606         (XXXVII)âTHJ-2201 (1-(5-Fluoropentyl)-3-(1
  607  naphthoyl)indazole).
  608         (XXXVIII)âMAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1
  609  naphthoyl)indole).
  610         (XXXIX)âEAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1
  611  naphthoyl)indole).
  612         (XL)âEG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).
  613         (XLI)âEG-2201 (9-(5-Fluoropentyl)-3-(1
  614  naphthoyl)carbazole).
  615         c.âNaphthoylpyrroles.âAny compound containing a
  616  naphthoylpyrrole structure, with or without substitution on the
  617  pyrrole ring to any extent, whether or not substituted on the
  618  naphthyl ring to any extent, including, but not limited to:
  619         (I)âJWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
  620         (II)âJWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
  621         (III)âJWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  622         (IV)âJWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  623         (V)âJWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  624         (VI)âJWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1
  625  naphthoyl)pyrrole).
  626         (VII)âJWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1
  627  naphthoyl)pyrrole).
  628         (VIII)âJWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1
  629  naphthoyl)pyrrole).
  630         (IX)âJWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1
  631  naphthoyl)pyrrole).
  632         (X)âJWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1
  633  naphthoyl)pyrrole).
  634         d.âNaphthylmethylenindenes.âAny compound containing a
  635  naphthylmethylenindene structure, with or without substitution
  636  at the 3-position of the indene ring to any extent, whether or
  637  not substituted on the naphthyl ring to any extent, including,
  638  but not limited to, JWH-176 (3-Pentyl-1
  639  (naphthylmethylene)indene).
  640         e.âPhenylacetylindoles and Phenylacetylindazoles.âAny
  641  compound containing a phenylacetylindole or phenylacetylindazole
  642  structure, with or without substitution on the indole or
  643  indazole ring to any extent, whether or not substituted on the
  644  phenyl ring to any extent, including, but not limited to:
  645         (I)âJWH-167 (1-Pentyl-3-(phenylacetyl)indole).
  646         (II)âJWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
  647         (III)âJWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
  648         (IV)âJWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
  649         (V)âJWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
  650         (VI)âJWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
  651         (VII)âCannabipiperidiethanone.
  652         (VIII)âRCS-8 (1-(2-Cyclohexylethyl)-3-(2
  653  methoxyphenylacetyl)indole).
  654         f.âCyclohexylphenols.âAny compound containing a
  655  cyclohexylphenol structure, with or without substitution at the
  656  5-position of the phenolic ring to any extent, whether or not
  657  substituted on the cyclohexyl ring to any extent, including, but
  658  not limited to:
  659         (I)âCP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
  660  yl)phenol).
  661         (II)âCannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
  662  homologue).
  663         (III)âCP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2
  664  methyloctan-2-yl)phenol).
  665         g.âBenzoylindoles and Benzoylindazoles.âAny compound
  666  containing a benzoylindole or benzoylindazole structure, with or
  667  without substitution on the indole or indazole ring to any
  668  extent, whether or not substituted on the phenyl ring to any
  669  extent, including, but not limited to:
  670         (I)âAM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
  671         (II)âAM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
  672         (III)âAM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  673  iodo-5-nitrobenzoyl)indole).
  674         (IV)âPravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4
  675  methoxybenzoyl)indole).
  676         (V)âAM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  677  iodobenzoyl)indole).
  678         (VI)âRCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
  679         (VII)âRCS-4 C4 homologue (1-Butyl-3-(4
  680  methoxybenzoyl)indole).
  681         (VIII)âAM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo
  682  3-(4-methoxybenzoyl)indole).
  683         h.âTetramethylcyclopropanoylindoles and
  684  Tetramethylcyclopropanoylindazoles.âAny compound containing a
  685  tetramethylcyclopropanoylindole or
  686  tetramethylcyclopropanoylindazole structure, with or without
  687  substitution on the indole or indazole ring to any extent,
  688  whether or not substituted on the tetramethylcyclopropyl group
  689  to any extent, including, but not limited to:
  690         (I)âUR-144 (1-Pentyl-3-(2,2,3,3
  691  tetramethylcyclopropanoyl)indole).
  692         (II)âXLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
  693  tetramethylcyclopropanoyl)indole).
  694         (III)âChloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
  695  tetramethylcyclopropanoyl)indole).
  696         (IV)âA-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3
  697  tetramethylcyclopropanoyl)indole).
  698         (V)âA-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3
  699  tetramethylcyclopropanoyl)indole).
  700         (VI)âM-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3
  701  tetramethylcyclopropanoyl)indole).
  702         (VII)âFUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3
  703  tetramethylcyclopropanoyl)indole).
  704         (VIII)âFAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3
  705  tetramethylcyclopropanoyl)indazole).
  706         (IX)âXLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3
  707  tetramethylcyclopropanoyl)indole).
  708         (X)âAB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3
  709  tetramethylcyclopropanoyl)indole).
  710         i.âAdamantoylindoles, Adamantoylindazoles, Adamantylindole
  711  carboxamides, and Adamantylindazole carboxamides.âAny compound
  712  containing an adamantoyl indole, adamantoyl indazole, adamantyl
  713  indole carboxamide, or adamantyl indazole carboxamide structure,
  714  with or without substitution on the indole or indazole ring to
  715  any extent, whether or not substituted on the adamantyl ring to
  716  any extent, including, but not limited to:
  717         (I)âAKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
  718         (II)âFluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
  719  3-carboxamide).
  720         (III)âSTS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
  721  carboxamide).
  722         (IV)âAM-1248 (1-(1-Methylpiperidine)methyl-3-(1
  723  adamantoyl)indole).
  724         (V)âAB-001 (1-Pentyl-3-(1-adamantoyl)indole).
  725         (VI)âAPICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
  726         (VII)âFluoro AB-001 (1-(Fluoropentyl)-3-(1
  727  adamantoyl)indole).
  728         j.âQuinolinylindolecarboxylates,
  729  Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
  730  and Quinolinylindazolecarboxamides.âAny compound containing a
  731  quinolinylindole carboxylate, quinolinylindazole carboxylate,
  732  isoquinolinylindole carboxylate, isoquinolinylindazole
  733  carboxylate, quinolinylindole carboxamide, quinolinylindazole
  734  carboxamide, isoquinolinylindole carboxamide, or
  735  isoquinolinylindazole carboxamide structure, with or without
  736  substitution on the indole or indazole ring to any extent,
  737  whether or not substituted on the quinoline or isoquinoline ring
  738  to any extent, including, but not limited to:
  739         (I)âPB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
  740         (II)âFluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
  741  carboxylate).
  742         (III)âBB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
  743  carboxylate).
  744         (IV)âFUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
  745  carboxylate).
  746         (V)âNPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
  747         (VI)âFluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole
  748  3-carboxylate).
  749         (VII)âFUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole
  750  3-carboxylate).
  751         (VIII)âTHJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
  752         (IX)âFluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3
  753  carboxamide).
  754         k.âNaphthylindolecarboxylates and
  755  Naphthylindazolecarboxylates.âAny compound containing a
  756  naphthylindole carboxylate or naphthylindazole carboxylate
  757  structure, with or without substitution on the indole or
  758  indazole ring to any extent, whether or not substituted on the
  759  naphthyl ring to any extent, including, but not limited to:
  760         (I)âNM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3
  761  carboxylate).
  762         (II)âSDB-005 (1-Naphthalenyl 1-pentylindazole-3
  763  carboxylate).
  764         (III)âFluoro SDB-005 (1-Naphthalenyl 1
  765  (fluoropentyl)indazole-3-carboxylate).
  766         (IV)âFDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3
  767  carboxylate).
  768         (V)â3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3
  769  carboxylate).
  770         l.âNaphthylindole carboxamides and Naphthylindazole
  771  carboxamides.âAny compound containing a naphthylindole
  772  carboxamide or naphthylindazole carboxamide structure, with or
  773  without substitution on the indole or indazole ring to any
  774  extent, whether or not substituted on the naphthyl ring to any
  775  extent, including, but not limited to:
  776         (I)âNNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
  777         (II)âFluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
  778  3-carboxamide).
  779         (III)âChloro-NNEI (N-Naphthalen-1-yl 1
  780  (chloropentyl)indole-3-carboxamide).
  781         (IV)âMN-18 (N-Naphthalen-1-yl 1-pentylindazole-3
  782  carboxamide).
  783         (V)âFluoro MN-18 (N-Naphthalen-1-yl 1
  784  (fluoropentyl)indazole-3-carboxamide).
  785         m.âAlkylcarbonyl indole carboxamides, Alkylcarbonyl
  786  indazole carboxamides, Alkylcarbonyl indole carboxylates, and
  787  Alkylcarbonyl indazole carboxylates.âAny compound containing an
  788  alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
  789  1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3
  790  phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
  791  indole carboxamide, indazole carboxamide, indole carboxylate, or
  792  indazole carboxylate, with or without substitution on the indole
  793  or indazole ring to any extent, whether or not substituted on
  794  the alkylcarbonyl group to any extent, including, but not
  795  limited to:
  796         (I)âADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1
  797  pentylindole-3-carboxamide).
  798         (II)âFluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  799  yl)-1-(fluoropentyl)indole-3-carboxamide).
  800         (III)âFluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  801  (fluoropentyl)indole-3-carboxamide).
  802         (IV)âAB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  803  pentylindazole-3-carboxamide).
  804         (V)âFluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)
  805  1-(fluoropentyl)indazole-3-carboxamide).
  806         (VI)âADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
  807  1-pentylindazole-3-carboxamide).
  808         (VII)âFluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1
  809  oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
  810         (VIII)âAB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  811  (4-fluorobenzyl)indazole-3-carboxamide).
  812         (IX)âADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  813  yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
  814         (X)âAB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  815  (cyclohexylmethyl)indazole-3-carboxamide).
  816         (XI)âMA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  817  (cyclohexylmethyl)indazole-3-carboxamide).
  818         (XII)âMAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  819  yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
  820         (XIII)âAMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  821  pentylindazole-3-carboxamide).
  822         (XIV)âFluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  823  (fluoropentyl)indazole-3-carboxamide).
  824         (XV)âFUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4
  825  fluorobenzyl)indazole-3-carboxamide).
  826         (XVI)âMDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  827  2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
  828         (XVII)âMDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  829  2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
  830         (XVIII)âMDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  831  2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
  832         (XIX)âPX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
  833  fluoropentyl)indole-3-carboxamide).
  834         (XX)âPX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
  835  fluoropentyl)indazole-3-carboxamide).
  836         (XXI)âPX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1
  837  (cyclohexylmethyl)indazole-3-carboxamide).
  838         (XXII)âPX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4
  839  fluorobenzyl)indazole-3-carboxamide).
  840         (XXIII)âMO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  841  2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
  842         n.âCumylindolecarboxamides and Cumylindazolecarboxamides.
  843  Any compound containing a N-(2-phenylpropan-2-yl) indole
  844  carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
  845  structure, with or without substitution on the indole or
  846  indazole ring to any extent, whether or not substituted on the
  847  phenyl ring of the cumyl group to any extent, including, but not
  848  limited to:
  849         (I)âCUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3
  850  carboxamide).
  851         (II)âFluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1
  852  (fluoropentyl)indole-3-carboxamide).
  853         o.âOther Synthetic Cannabinoids.âAny material, compound,
  854  mixture, or preparation that contains any quantity of a
  855  Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
  856         (I)âWith or without modification or replacement of a
  857  carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
  858  between either two core rings, or linkage between a core ring
  859  and group structure, with or without the addition of a carbon or
  860  replacement of a carbon;
  861         (II)âWith or without replacement of a core ring or group
  862  structure, whether or not substituted on the ring or group
  863  structures to any extent; and
  864         (III)âIs a cannabinoid receptor agonist, unless
  865  specifically excepted or unless listed in another schedule or
  866  contained within a pharmaceutical product approved by the United
  867  States Food and Drug Administration.
  868         191.âSubstituted Cathinones.âUnless specifically excepted,
  869  listed in another schedule, or contained within a pharmaceutical
  870  product approved by the United States Food and Drug
  871  Administration, any material, compound, mixture, or preparation,
  872  including its salts, isomers, esters, or ethers, and salts of
  873  isomers, esters, or ethers, whenever the existence of such salts
  874  is possible within any of the following specific chemical
  875  designations:
  876         a.âAny compound containing a 2-amino-1-phenyl-1-propanone
  877  structure;
  878         b.âAny compound containing a 2-amino-1-naphthyl-1-propanone
  879  structure; or
  880         c.âAny compound containing a 2-amino-1-thiophenyl-1
  881  propanone structure,
  882  
  883  whether or not the compound is further modified:
  884         (I)âWith or without substitution on the ring system to any
  885  extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
  886  haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
  887  dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
  888  substituents;
  889         (II)âWith or without substitution at the 3-propanone
  890  position with an alkyl substituent or removal of the methyl
  891  group at the 3-propanone position;
  892         (III)âWith or without substitution at the 2-amino nitrogen
  893  atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
  894  not further substituted in the ring system; or
  895         (IV)âWith or without inclusion of the 2-amino nitrogen atom
  896  in a cyclic structure, including, but not limited to:
  897         (A)âMethcathinone.
  898         (B)âEthcathinone.
  899         (C)âMethylone (3,4-Methylenedioxymethcathinone).
  900         (D)â2,3-Methylenedioxymethcathinone.
  901         (E)âMDPV (3,4-Methylenedioxypyrovalerone).
  902         (F)âMethylmethcathinone.
  903         (G)âMethoxymethcathinone.
  904         (H)âFluoromethcathinone.
  905         (I)âMethylethcathinone.
  906         (J)âButylone (3,4-Methylenedioxy-alpha
  907  methylaminobutyrophenone).
  908         (K)âEthylone (3,4-Methylenedioxy-N-ethylcathinone).
  909         (L)âBMDP (3,4-Methylenedioxy-N-benzylcathinone).
  910         (M)âNaphyrone (Naphthylpyrovalerone).
  911         (N)âBromomethcathinone.
  912         (O)âBuphedrone (alpha-Methylaminobutyrophenone).
  913         (P)âEutylone (3,4-Methylenedioxy-alpha
  914  ethylaminobutyrophenone).
  915         (Q)âDimethylcathinone.
  916         (R)âDimethylmethcathinone.
  917         (S)âPentylone (3,4-Methylenedioxy-alpha
  918  methylaminovalerophenone).
  919         (T)âPentedrone (alpha-Methylaminovalerophenone).
  920         (U)âMDPPP (3,4-Methylenedioxy-alpha
  921  pyrrolidinopropiophenone).
  922         (V)âMDPBP (3,4-Methylenedioxy-alpha
  923  pyrrolidinobutyrophenone).
  924         (W)âMPPP (Methyl-alpha-pyrrolidinopropiophenone).
  925         (X)âPPP (Pyrrolidinopropiophenone).
  926         (Y)âPVP (Pyrrolidinovalerophenone) or
  927  (Pyrrolidinopentiophenone).
  928         (Z)âMOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
  929         (AA)âMPHP (Methyl-alpha-pyrrolidinohexanophenone).
  930         (BB)âF-MABP (Fluoromethylaminobutyrophenone).
  931         (CC)âMe-EABP (Methylethylaminobutyrophenone).
  932         (DD)âPBP (Pyrrolidinobutyrophenone).
  933         (EE)âMeO-PBP (Methoxypyrrolidinobutyrophenone).
  934         (FF)âEt-PBP (Ethylpyrrolidinobutyrophenone).
  935         (GG)â3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
  936         (HH)âDimethylone (3,4-Methylenedioxy-N,N
  937  dimethylcathinone).
  938         (II)â3,4-Methylenedioxy-N,N-diethylcathinone.
  939         (JJ)â3,4-Methylenedioxy-N-acetylcathinone.
  940         (KK)â3,4-Methylenedioxy-N-acetylmethcathinone.
  941         (LL)â3,4-Methylenedioxy-N-acetylethcathinone.
  942         (MM)âMethylbuphedrone (Methyl-alpha
  943  methylaminobutyrophenone).
  944         (NN)âMethyl-alpha-methylaminohexanophenone.
  945         (OO)âN-Ethyl-N-methylcathinone.
  946         (PP)âPHP (Pyrrolidinohexanophenone).
  947         (QQ)âPV8 (Pyrrolidinoheptanophenone).
  948         (RR)âChloromethcathinone.
  949         (SS)â4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
  950         192.âSubstituted Phenethylamines.âUnless specifically
  951  excepted or unless listed in another schedule, or contained
  952  within a pharmaceutical product approved by the United States
  953  Food and Drug Administration, any material, compound, mixture,
  954  or preparation, including its salts, isomers, esters, or ethers,
  955  and salts of isomers, esters, or ethers, whenever the existence
  956  of such salts is possible within any of the following specific
  957  chemical designations, any compound containing a phenethylamine
  958  structure, without a beta-keto group, and without a benzyl group
  959  attached to the amine group, whether or not the compound is
  960  further modified with or without substitution on the phenyl ring
  961  to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
  962  halide, fused alkylenedioxy, fused furan, fused benzofuran,
  963  fused dihydrofuran, or fused tetrahydropyran substituents,
  964  whether or not further substituted on a ring to any extent, with
  965  or without substitution at the alpha or beta position by any
  966  alkyl substituent, with or without substitution at the nitrogen
  967  atom, and with or without inclusion of the 2-amino nitrogen atom
  968  in a cyclic structure, including, but not limited to:
  969         a.â2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
  970         b.â2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
  971         c.â2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
  972         d.â2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
  973         e.â2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
  974         f.â2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
  975         g.â2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
  976         h.â2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
  977         i.â2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
  978         j.â2C-H (2,5-Dimethoxyphenethylamine).
  979         k.â2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
  980         l.â2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
  981         m.âMDMA (3,4-Methylenedioxymethamphetamine).
  982         n.âMBDB (Methylbenzodioxolylbutanamine) or (3,4
  983  Methylenedioxy-N-methylbutanamine).
  984         o.âMDA (3,4-Methylenedioxyamphetamine).
  985         p.â2,5-Dimethoxyamphetamine.
  986         q.âFluoroamphetamine.
  987         r.âFluoromethamphetamine.
  988         s.âMDEA (3,4-Methylenedioxy-N-ethylamphetamine).
  989         t.âDOB (4-Bromo-2,5-dimethoxyamphetamine).
  990         u.âDOC (4-Chloro-2,5-dimethoxyamphetamine).
  991         v.âDOET (4-Ethyl-2,5-dimethoxyamphetamine).
  992         w.âDOI (4-Iodo-2,5-dimethoxyamphetamine).
  993         x.âDOM (4-Methyl-2,5-dimethoxyamphetamine).
  994         y.âPMA (4-Methoxyamphetamine).
  995         z.âN-Ethylamphetamine.
  996         aa.â3,4-Methylenedioxy-N-hydroxyamphetamine.
  997         bb.â5-Methoxy-3,4-methylenedioxyamphetamine.
  998         cc.âPMMA (4-Methoxymethamphetamine).
  999         dd.âN,N-Dimethylamphetamine.
 1000         ee.â3,4,5-Trimethoxyamphetamine.
 1001         ff.â4-APB (4-(2-Aminopropyl)benzofuran).
 1002         gg.â5-APB (5-(2-Aminopropyl)benzofuran).
 1003         hh.â6-APB (6-(2-Aminopropyl)benzofuran).
 1004         ii.â7-APB (7-(2-Aminopropyl)benzofuran).
 1005         jj.â4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
 1006         kk.â5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
 1007         ll.â6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
 1008         mm.â7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
 1009         nn.â4-MAPB (4-(2-Methylaminopropyl)benzofuran).
 1010         oo.â5-MAPB (5-(2-Methylaminopropyl)benzofuran).
 1011         pp.â6-MAPB (6-(2-Methylaminopropyl)benzofuran).
 1012         qq.â7-MAPB (7-(2-Methylaminopropyl)benzofuran).
 1013         rr.â5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
 1014         ss.â5-MAPDB (5-(2-Methylaminopropyl)-2,3
 1015  dihydrobenzofuran),
 1016  
 1017  which does not include phenethylamine, mescaline as described in
 1018  subparagraph 20., substituted cathinones as described in
 1019  subparagraph 191., N-Benzyl phenethylamine compounds as
 1020  described in subparagraph 193., or methamphetamine as described
 1021  in subparagraph (2)(c)5.
 1022         193.âN-Benzyl Phenethylamine Compounds.âUnless specifically
 1023  excepted or unless listed in another schedule, or contained
 1024  within a pharmaceutical product approved by the United States
 1025  Food and Drug Administration, any material, compound, mixture,
 1026  or preparation, including its salts, isomers, esters, or ethers,
 1027  and salts of isomers, esters, or ethers, whenever the existence
 1028  of such salts is possible within any of the following specific
 1029  chemical designations, any compound containing a phenethylamine
 1030  structure without a beta-keto group, with substitution on the
 1031  nitrogen atom of the amino group with a benzyl substituent, with
 1032  or without substitution on the phenyl or benzyl ring to any
 1033  extent with alkyl, alkoxy, thio, alkylthio, halide, fused
 1034  alkylenedioxy, fused furan, fused benzofuran, or fused
 1035  tetrahydropyran substituents, whether or not further substituted
 1036  on a ring to any extent, with or without substitution at the
 1037  alpha position by any alkyl substituent, including, but not
 1038  limited to:
 1039         a.â25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
 1040  methoxybenzyl)]phenethylamine).
 1041         b.â25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2
 1042  hydroxybenzyl)]phenethylamine).
 1043         c.â25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2
 1044  fluorobenzyl)]phenethylamine).
 1045         d.â25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3
 1046  methylenedioxybenzyl)]phenethylamine).
 1047         e.â25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
 1048  methoxybenzyl)]phenethylamine).
 1049         f.â25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2
 1050  hydroxybenzyl)]phenethylamine).
 1051         g.â25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2
 1052  fluorobenzyl)]phenethylamine).
 1053         h.â25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3
 1054  methylenedioxybenzyl)]phenethylamine).
 1055         i.â25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2
 1056  methoxybenzyl)]phenethylamine).
 1057         j.â25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2
 1058  methoxybenzyl)]phenethylamine).
 1059         k.â25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2
 1060  methoxybenzyl)]phenethylamine).
 1061         l.â25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
 1062  methoxybenzyl)]phenethylamine).
 1063         m.â25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2
 1064  hydroxybenzyl)]phenethylamine).
 1065         n.â25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2
 1066  fluorobenzyl)]phenethylamine).
 1067         o.â25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3
 1068  methylenedioxybenzyl)]phenethylamine).
 1069         p.â25H-NBOMe (2,5-Dimethoxy-[N-(2
 1070  methoxybenzyl)]phenethylamine).
 1071         q.â25H-NBOH (2,5-Dimethoxy-[N-(2
 1072  hydroxybenzyl)]phenethylamine).
 1073         r.â25H-NBF (2,5-Dimethoxy-[N-(2
 1074  fluorobenzyl)]phenethylamine).
 1075         s.â25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2
 1076  methoxybenzyl)]phenethylamine),
 1077  
 1078  which does not include substituted cathinones as described in
 1079  subparagraph 191.
 1080         194.âSubstituted Tryptamines.âUnless specifically excepted
 1081  or unless listed in another schedule, or contained within a
 1082  pharmaceutical product approved by the United States Food and
 1083  Drug Administration, any material, compound, mixture, or
 1084  preparation containing a 2-(1H-indol-3-yl)ethanamine, for
 1085  example tryptamine, structure with or without mono- or di
 1086  substitution of the amine nitrogen with alkyl or alkenyl groups,
 1087  or by inclusion of the amino nitrogen atom in a cyclic
 1088  structure, whether or not substituted at the alpha position with
 1089  an alkyl group, whether or not substituted on the indole ring to
 1090  any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
 1091  groups, including, but not limited to:
 1092         a.âAlpha-Ethyltryptamine.
 1093         b.âBufotenine.
 1094         c.âDET (Diethyltryptamine).
 1095         d.âDMT (Dimethyltryptamine).
 1096         e.âMET (N-Methyl-N-ethyltryptamine).
 1097         f.âDALT (N,N-Diallyltryptamine).
 1098         g.âEiPT (N-Ethyl-N-isopropyltryptamine).
 1099         h.âMiPT (N-Methyl-N-isopropyltryptamine).
 1100         i.â5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
 1101         j.â5-Hydroxy-N-methyltryptamine.
 1102         k.â5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
 1103         l.â5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
 1104         m.âMethyltryptamine.
 1105         n.â5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
 1106         o.â5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
 1107         p.â5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
 1108         q.âDiPT (N,N-Diisopropyltryptamine).
 1109         r.âDPT (N,N-Dipropyltryptamine).
 1110         s.â4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
 1111         t.â5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
 1112         u.â4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
 1113         v.â4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
 1114         w.â4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
 1115         x.â4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
 1116         y.â4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N
 1117  isopropyltryptamine).
 1118         z.âMethyl-alpha-ethyltryptamine.
 1119         aa.âBromo-DALT (Bromo-N,N-diallyltryptamine),
 1120  
 1121  which does not include tryptamine, psilocyn as described in
 1122  subparagraph 34., or psilocybin as described in subparagraph 33.
 1123         195.âSubstituted Phenylcyclohexylamines.âUnless
 1124  specifically excepted or unless listed in another schedule, or
 1125  contained within a pharmaceutical product approved by the United
 1126  States Food and Drug Administration, any material, compound,
 1127  mixture, or preparation containing a phenylcyclohexylamine
 1128  structure, with or without any substitution on the phenyl ring,
 1129  any substitution on the cyclohexyl ring, any replacement of the
 1130  phenyl ring with a thiophenyl or benzothiophenyl ring, with or
 1131  without substitution on the amine with alkyl, dialkyl, or alkoxy
 1132  substituents, inclusion of the nitrogen in a cyclic structure,
 1133  or any combination of the above, including, but not limited to:
 1134         a.âBTCP (Benzothiophenylcyclohexylpiperidine) or BCP
 1135  (Benocyclidine).
 1136         b.âPCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
 1137  of phencyclidine).
 1138         c.âPCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
 1139  analog of phencyclidine).
 1140         d.âPCPr (Phenylcyclohexylpropylamine).
 1141         e.âTCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
 1142  analog of phencyclidine).
 1143         f.âPCEEA (Phenylcyclohexyl(ethoxyethylamine)).
 1144         g.âPCMPA (Phenylcyclohexyl(methoxypropylamine)).
 1145         h.âMethoxetamine.
 1146         i.â3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
 1147         j.âBromo-PCP ((Bromophenyl)cyclohexylpiperidine).
 1148         k.âChloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
 1149         l.âFluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
 1150         m.âHydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
 1151         n.âMethoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
 1152         o.âMethyl-PCP ((Methylphenyl)cyclohexylpiperidine).
 1153         p.âNitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
 1154         q.âOxo-PCP ((Oxophenyl)cyclohexylpiperidine).
 1155         r.âAmino-PCP ((Aminophenyl)cyclohexylpiperidine).
 1156         196.âW-15, 4-chloro-N-[1-(2-phenylethyl)-2
 1157  piperidinylidene]-benzenesulfonamide.
 1158         197.âW-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2
 1159  piperidinylidene]-benzenesulfonamide.
 1160         198.âAH-7921, 3,4-dichloro-N-[[1
 1161  (dimethylamino)cyclohexyl]methyl]-benzamide.
 1162         199.âU47700, trans-3,4-dichloro-N-[2
 1163  (dimethylamino)cyclohexyl]-N-methyl-benzamide.
 1164         200.âMT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
 1165  dihydrochloride.
 1166         Section 2.âParagraph (i) of subsection (1) of section
 1167  893.13, Florida Statutes, is amended to read:
 1168         893.13âProhibited acts; penalties.â
 1169         (1)
 1170         (i)âExcept as authorized by this chapter, a person commits
 1171  a felony of the first degree, punishable as provided in s.
 1172  775.082, s. 775.083, or s. 775.084, and must be sentenced to a
 1173  mandatory minimum term of imprisonment of 3 years, if:
 1174         1.âThe person sells, manufactures, or delivers, or
 1175  possesses with intent to sell, manufacture, or deliver, any of
 1176  the following:
 1177         a.âAlfentanil, as described in s. 893.03(2)(b)1.;
 1178         b.âCarfentanil, as described in s. 893.03(2)(b)6.;
 1179         c.âFentanyl, as described in s. 893.03(2)(b)9.;
 1180         d.âSufentanil, as described in s. 893.03(2)(b)30.;
 1181         e.âA fentanyl derivative, as described in s.
 1182  893.03(1)(a)63.;
 1183         f.â<u class="Insert">Xylazine, as described in s. 893.03(1)(c)37.;</u>
 1184         <u class="Insert">g.</u>âA controlled substance analog, as described in s.
 1185  893.0356, of any substance described in sub-subparagraphs <u class="Insert">a.-f.</u>
 1186  <s class="Remove">a.-e.</s>; or
 1187         <u class="Insert">h.</u><s class="Remove">g.</s>âA mixture containing any substance described in sub
 1188  subparagraphs <u class="Insert">a.-g.</u> <s class="Remove">a.-f.</s>; and
 1189         2.âThe substance or mixture listed in subparagraph 1. is in
 1190  a form that resembles, or is mixed, granulated, absorbed, spray
 1191  dried, or aerosolized as or onto, coated on, in whole or in
 1192  part, or solubilized with or into, a product, when such product
 1193  or its packaging further has at least one of the following
 1194  attributes:
 1195         a.âResembles the trade dress of a branded food product,
 1196  consumer food product, or logo food product;
 1197         b.âIncorporates an actual or fake registered copyright,
 1198  service mark, or trademark;
 1199         c.âResembles candy, cereal, a gummy, a vitamin, or a
 1200  chewable product, such as a gum or gelatin-based product; or
 1201         d.âContains a cartoon character imprint.
 1202         Section 3.âParagraph (c) of subsection (1) of section
 1203  893.135, Florida Statutes, is amended to read:
 1204         893.135âTrafficking; mandatory sentences; suspension or
 1205  reduction of sentences; conspiracy to engage in trafficking.â
 1206         (1)âExcept as authorized in this chapter or in chapter 499
 1207  and notwithstanding the provisions of s. 893.13:
 1208         (c)1.âA person who knowingly sells, purchases,
 1209  manufactures, delivers, or brings into this state, or who is
 1210  knowingly in actual or constructive possession of, 4 grams or
 1211  more of any morphine, opium, hydromorphone, or any salt,
 1212  derivative, isomer, or salt of an isomer thereof, including
 1213  heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or
 1214  (3)(c)4., or 4 grams or more of any mixture containing any such
 1215  substance, but less than 30 kilograms of such substance or
 1216  mixture, commits a felony of the first degree, which felony
 1217  shall be known as âtrafficking in illegal drugs,â punishable as
 1218  provided in s. 775.082, s. 775.083, or s. 775.084. If the
 1219  quantity involved:
 1220         a.âIs 4 grams or more, but less than 14 grams, such person
 1221  shall be sentenced to a mandatory minimum term of imprisonment
 1222  of 3 years and shall be ordered to pay a fine of $50,000.
 1223         b.âIs 14 grams or more, but less than 28 grams, such person
 1224  shall be sentenced to a mandatory minimum term of imprisonment
 1225  of 15 years and shall be ordered to pay a fine of $100,000.
 1226         c.âIs 28 grams or more, but less than 30 kilograms, such
 1227  person shall be sentenced to a mandatory minimum term of
 1228  imprisonment of 25 years and shall be ordered to pay a fine of
 1229  $500,000.
 1230         2.âA person who knowingly sells, purchases, manufactures,
 1231  delivers, or brings into this state, or who is knowingly in
 1232  actual or constructive possession of, 28 grams or more of
 1233  hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as
 1234  described in s. 893.03(2)(a)1.g., or any salt thereof, or 28
 1235  grams or more of any mixture containing any such substance,
 1236  commits a felony of the first degree, which felony shall be
 1237  known as âtrafficking in hydrocodone,â punishable as provided in
 1238  s. 775.082, s. 775.083, or s. 775.084. If the quantity involved:
 1239         a.âIs 28 grams or more, but less than 50 grams, such person
 1240  shall be sentenced to a mandatory minimum term of imprisonment
 1241  of 3 years and shall be ordered to pay a fine of $50,000.
 1242         b.âIs 50 grams or more, but less than 100 grams, such
 1243  person shall be sentenced to a mandatory minimum term of
 1244  imprisonment of 7 years and shall be ordered to pay a fine of
 1245  $100,000.
 1246         c.âIs 100 grams or more, but less than 300 grams, such
 1247  person shall be sentenced to a mandatory minimum term of
 1248  imprisonment of 15 years and shall be ordered to pay a fine of
 1249  $500,000.
 1250         d.âIs 300 grams or more, but less than 30 kilograms, such
 1251  person shall be sentenced to a mandatory minimum term of
 1252  imprisonment of 25 years and shall be ordered to pay a fine of
 1253  $750,000.
 1254         3.âA person who knowingly sells, purchases, manufactures,
 1255  delivers, or brings into this state, or who is knowingly in
 1256  actual or constructive possession of, 7 grams or more of
 1257  oxycodone, as described in s. 893.03(2)(a)1.q., or any salt
 1258  thereof, or 7 grams or more of any mixture containing any such
 1259  substance, commits a felony of the first degree, which felony
 1260  shall be known as âtrafficking in oxycodone,â punishable as
 1261  provided in s. 775.082, s. 775.083, or s. 775.084. If the
 1262  quantity involved:
 1263         a.âIs 7 grams or more, but less than 14 grams, such person
 1264  shall be sentenced to a mandatory minimum term of imprisonment
 1265  of 3 years and shall be ordered to pay a fine of $50,000.
 1266         b.âIs 14 grams or more, but less than 25 grams, such person
 1267  shall be sentenced to a mandatory minimum term of imprisonment
 1268  of 7 years and shall be ordered to pay a fine of $100,000.
 1269         c.âIs 25 grams or more, but less than 100 grams, such
 1270  person shall be sentenced to a mandatory minimum term of
 1271  imprisonment of 15 years and shall be ordered to pay a fine of
 1272  $500,000.
 1273         d.âIs 100 grams or more, but less than 30 kilograms, such
 1274  person shall be sentenced to a mandatory minimum term of
 1275  imprisonment of 25 years and shall be ordered to pay a fine of
 1276  $750,000.
 1277         4.a.âA person who knowingly sells, purchases, manufactures,
 1278  delivers, or brings into this state, or who is knowingly in
 1279  actual or constructive possession of, 4 grams or more of:
 1280         (I)âAlfentanil, as described in s. 893.03(2)(b)1.;
 1281         (II)âCarfentanil, as described in s. 893.03(2)(b)6.;
 1282         (III)âFentanyl, as described in s. 893.03(2)(b)9.;
 1283         (IV)âSufentanil, as described in s. 893.03(2)(b)30.;
 1284         (V)âA fentanyl derivative, as described in s.
 1285  893.03(1)(a)63.;
 1286         (VI)âA controlled substance analog, as described in s.
 1287  893.0356, of any substance described in sub-sub-subparagraphs
 1288  (I)-(V); or
 1289         (VII)âA mixture containing any substance described in sub
 1290  sub-subparagraphs (I)-(VI),
 1291  
 1292  commits a felony of the first degree, which felony shall be
 1293  known as âtrafficking in dangerous fentanyl or fentanyl
 1294  analogues,â punishable as provided in s. 775.082, s. 775.083, or
 1295  s. 775.084.
 1296         b.âIf the quantity involved under sub-subparagraph a.:
 1297         (I)âIs 4 grams or more, but less than 14 grams, such person
 1298  shall be sentenced to a mandatory minimum term of imprisonment
 1299  of 7 years<s class="Remove">,</s> and shall be ordered to pay a fine of $50,000.
 1300         (II)âIs 14 grams or more, but less than 28 grams, such
 1301  person shall be sentenced to a mandatory minimum term of
 1302  imprisonment of 20 years<s class="Remove">,</s> and shall be ordered to pay a fine of
 1303  $100,000.
 1304         (III)âIs 28 grams or more, such person shall be sentenced
 1305  to a mandatory minimum term of imprisonment of 25 years<s class="Remove">,</s> and
 1306  shall be ordered to pay a fine of $500,000.
 1307         c.âA person 18 years of age or older who violates sub
 1308  subparagraph a. by knowingly selling or delivering to a minor at
 1309  least 4 grams of a substance or mixture listed in sub
 1310  subparagraph a. shall be sentenced to a mandatory minimum term
 1311  of not less than 25 years and not exceeding life imprisonment,
 1312  and shall be ordered to pay a fine of $1 million if the
 1313  substance or mixture listed in sub-subparagraph a. is in a form
 1314  that resembles, or is mixed, granulated, absorbed, spray-dried,
 1315  or aerosolized as or onto, coated on, in whole or in part, or
 1316  solubilized with or into, a product, when such product or its
 1317  packaging further has at least one of the following attributes:
 1318         (I)âResembles the trade dress of a branded food product,
 1319  consumer food product, or logo food product;
 1320         (II)âIncorporates an actual or fake registered copyright,
 1321  service mark, or trademark;
 1322         (III)âResembles candy, cereal, a gummy, a vitamin, or a
 1323  chewable product, such as a gum or gelatin-based product; or
 1324         (IV)âContains a cartoon character imprint.
 1325         5.âA person who knowingly sells, purchases, manufactures,
 1326  delivers, or brings into this state, or who is knowingly in
 1327  actual or constructive possession of, 30 kilograms or more of
 1328  any morphine, opium, oxycodone, hydrocodone, codeine,
 1329  hydromorphone, or any salt, derivative, isomer, or salt of an
 1330  isomer thereof, including heroin, as described in s.
 1331  893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or
 1332  more of any mixture containing any such substance, commits the
 1333  first degree felony of trafficking in illegal drugs. A person
 1334  who has been convicted of the first degree felony of trafficking
 1335  in illegal drugs under this subparagraph shall be punished by
 1336  life imprisonment and is ineligible for any form of
 1337  discretionary early release except pardon or executive clemency
 1338  or conditional medical release under s. 947.149. However, if the
 1339  court determines that, in addition to committing any act
 1340  specified in this paragraph:
 1341         a.âThe person intentionally killed an individual or
 1342  counseled, commanded, induced, procured, or caused the
 1343  intentional killing of an individual and such killing was the
 1344  result; or
 1345         b.âThe personâs conduct in committing that act led to a
 1346  natural, though not inevitable, lethal result,
 1347  
 1348  such person commits the capital felony of trafficking in illegal
 1349  drugs, punishable as provided in ss. 775.082 and 921.142. A
 1350  person sentenced for a capital felony under this paragraph shall
 1351  also be sentenced to pay the maximum fine provided under
 1352  subparagraph 1.
 1353         6.âA person who knowingly brings into this state 60
 1354  kilograms or more of any morphine, opium, oxycodone,
 1355  hydrocodone, codeine, hydromorphone, or any salt, derivative,
 1356  isomer, or salt of an isomer thereof, including heroin, as
 1357  described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or
 1358  60 kilograms or more of any mixture containing any such
 1359  substance, and who knows that the probable result of such
 1360  importation would be the death of a person, commits capital
 1361  importation of illegal drugs, a capital felony punishable as
 1362  provided in ss. 775.082 and 921.142. A person sentenced for a
 1363  capital felony under this paragraph shall also be sentenced to
 1364  pay the maximum fine provided under subparagraph 1.
 1365         <u class="Insert">7.</u><u class="Insert">â</u><u class="Insert">A person who knowingly sells, purchases, manufactures,</u>
 1366  <u class="Insert">delivers, or brings into this state, or who is knowingly in</u>
 1367  <u class="Insert">actual or constructive possession of, 28 grams or more of</u>
 1368  <u class="Insert">xylazine as described in s. 893.03(1)(c)37. or any salt thereof,</u>
 1369  <u class="Insert">or 28 grams or more of any mixture containing any such</u>
 1370  <u class="Insert">substance, commits a felony of the first degree, which felony</u>
 1371  <u class="Insert">shall be known as âtrafficking in xylazine,â punishable as</u>
 1372  <u class="Insert">provided in s. 775.082, s. 775.083, or s. 775.084. If the</u>
 1373  <u class="Insert">quantity involved:</u>
 1374         <u class="Insert">a.</u><u class="Insert">â</u><u class="Insert">Is 28 grams or more, but less than 100 grams, such</u>
 1375  <u class="Insert">person shall be sentenced to a mandatory minimum term of</u>
 1376  <u class="Insert">imprisonment of 3 years and shall be ordered to pay a fine of</u>
 1377  <u class="Insert">$100,000.</u>
 1378         <u class="Insert">b.</u><u class="Insert">â</u><u class="Insert">Is 100 grams or more, but less than 200 grams, such</u>
 1379  <u class="Insert">person shall be sentenced to a mandatory minimum term of</u>
 1380  <u class="Insert">imprisonment of 7 years and shall be ordered to pay a fine of</u>
 1381  <u class="Insert">$100,000.</u>
 1382         <u class="Insert">c.</u><u class="Insert">â</u><u class="Insert">Is 200 grams or more, such person shall be sentenced to</u>
 1383  <u class="Insert">a mandatory minimum term of imprisonment of 25 years and shall</u>
 1384  <u class="Insert">be ordered to pay a fine of $500,000.</u>
 1385         Section 4.âExcept as otherwise expressly provided in this
 1386  act and except for this section, which shall take effect July 1,
 1387  2026, this act shall take effect October 1, 2026.

</pre>
</body>
</html>
